Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
Plos One
|
July 27, 2019
Artefact-free topography based scleral-asymmetry
Ahmed Abass, Bernardo T Lopes, Ashkan Eliasy, et al.
Patient Preference and Adherence
|
August 10, 2023
I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options
Maria Hollmen, Tom Bromilow, Adam B Smith, et al.
Journal of Substance Abuse Treatment
|
July 24, 2018
High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns
Philip N Murphy, Faizal Mohammed, Michelle Wareing, et al.
BMJ Open Respiratory Research
|
July 2, 2019
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease
Fasihul Khan, Iain Stewart, Lucy Howard, et al.
Neonatology
|
September 13, 2021
Less-Invasive Surfactant Administration for Neonatal Respiratory Distress Syndrome: A Consensus Guideline
Peter Reynolds, Porus Bustani, Colm Darby, et al.
Nature
|
April 15, 2020
Eugenics history: university geneticists respond
Andrew Pomiankowski, Mark G Thomas, Steve Jones, et al.
Plos One
|
February 19, 2021
Compressive behaviour of soft contact lenses and its effect on refractive power on the eye and handling off the eye
Ahmad H Shihab, Ashkan Eliasy, Bernardo T Lopes, et al.
Radiation Research
|
August 17, 2023
An Epidemiological Study of Lung Cancer and Selected Other Cancers among Namibian Uranium Workers
Raymond Agius, Evridiki Batistatou, Matthew Gittins, et al.
Neurobiology of Disease
|
March 15, 2011
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
Chiranjeevi Sandi, Ricardo Mouro Pinto, Sahar Al-Mahdawi, et al.
Patient Preference and Adherence
|
August 10, 2023
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options
Maria Hollmen, Marlies Wijsenbeek, Tom Bromilow, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
Plos One
|
July 27, 2019
Artefact-free topography based scleral-asymmetry
Ahmed Abass, Bernardo T Lopes, Ashkan Eliasy, et al.
Patient Preference and Adherence
|
August 10, 2023
I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options
Maria Hollmen, Tom Bromilow, Adam B Smith, et al.
Journal of Substance Abuse Treatment
|
July 24, 2018
High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns
Philip N Murphy, Faizal Mohammed, Michelle Wareing, et al.
BMJ Open Respiratory Research
|
July 2, 2019
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease
Fasihul Khan, Iain Stewart, Lucy Howard, et al.
Neonatology
|
September 13, 2021
Less-Invasive Surfactant Administration for Neonatal Respiratory Distress Syndrome: A Consensus Guideline
Peter Reynolds, Porus Bustani, Colm Darby, et al.
Nature
|
April 15, 2020
Eugenics history: university geneticists respond
Andrew Pomiankowski, Mark G Thomas, Steve Jones, et al.
Plos One
|
February 19, 2021
Compressive behaviour of soft contact lenses and its effect on refractive power on the eye and handling off the eye
Ahmad H Shihab, Ashkan Eliasy, Bernardo T Lopes, et al.
Radiation Research
|
August 17, 2023
An Epidemiological Study of Lung Cancer and Selected Other Cancers among Namibian Uranium Workers
Raymond Agius, Evridiki Batistatou, Matthew Gittins, et al.
Neurobiology of Disease
|
March 15, 2011
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
Chiranjeevi Sandi, Ricardo Mouro Pinto, Sahar Al-Mahdawi, et al.
Patient Preference and Adherence
|
August 10, 2023
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options
Maria Hollmen, Marlies Wijsenbeek, Tom Bromilow, et al.
Page
of 12